LUFYLLIN Drug Patent Profile
✉ Email this page to a colleague
When do Lufyllin patents expire, and what generic alternatives are available?
Lufyllin is a drug marketed by Pharmobedient and is included in one NDA.
The generic ingredient in LUFYLLIN is dyphylline. There is one drug master file entry for this compound. Additional details are available on the dyphylline profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LUFYLLIN?
- What are the global sales for LUFYLLIN?
- What is Average Wholesale Price for LUFYLLIN?
Summary for LUFYLLIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 91 |
| Patent Applications: | 3,846 |
| DailyMed Link: | LUFYLLIN at DailyMed |
US Patents and Regulatory Information for LUFYLLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmobedient | LUFYLLIN | dyphylline | TABLET;ORAL | 084566-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmobedient | LUFYLLIN | dyphylline | TABLET;ORAL | 084566-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
